Discussions on the use of interleukin-6 inhibitors, including tocilizumab (Actemra) and sarilumab (Kevzara), in COVID-19 patients may continue. Improved survival. In COVACTA trialNo significant difference in...
A black doctor who has since died of COVID-19 said she believed she had not been properly treated by hospital doctors and that racism was affecting...
Since the new coronavirus that causes COVID-19 has become a global public health threat, it has been said that the pandemic will not end until a...
The FDA Advisory Board has overwhelmingly voted against the data presented on the controversial Alzheimer’s disease candidate aducanumab Friday. The authorities’ Peripheral and Central Nervous System...
Researchers have found that many YouTube videos about COVID-19 contain inaccurate information about cures, cures, and even conspiracy theories. Heidi Oi-Yee Li, a medical student, has...
Recent Comments